Viraj earned a PhD in Human Genetics from Baylor College of Medicine then completed two postdoctoral fellowships at the U.S. FDA and the University of Maryland spanning immunology, virology, drug delivery and nanotechnology.

Viraj then transitioned into portfolio management roles in medical countermeasures for the U.S. Department of Defense.

His leadership of Lactiga’s research and intellectual property programs has led to 3 issued patents, registered trademarks, an NIH Emergency Award, several additional awards, and Sponsored Research Agreements with multiple research institutions.

• 

  Chief Scientific Officer (CSO) in Lactiga

  Developing novel antibodies for mucosal infections in rare immunodeficiencies

• 

  Co-Founder in Lactiga

  Developing novel antibodies for mucosal infections in rare immunodeficiencies